Home › Asthma › NCT06068335
Innate Immunity in Allergic Asthma
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Participants must be at least 18 years of age * no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma. Exclusion Criteria: * Pregnant women and prisoners will be excluded from the study. * Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded.
About the study
The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic disease state ex vivo. This type 2 signature will be multi-hierarchical in nature and will be comprised cell surface receptor expression, pathway activation, and gene upregulation.
Sponsor: University of Central Florida · Participants: 100 · Started: Oct 18, 2021
Contact the study team
- Amoy Fraser, PhD, CCRP, PMP · Phone: 4072668742
- Erica Martin, B.S. · Phone: 4072668742
Official record on ClinicalTrials.gov — NCT06068335
Locations in the U.S.
| Florida | University of Central Florida, Orlando |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.